Comparison of Two Types of Bone Grafts in Patients Who Need One of Their Front Teeth Removed and Replaced With an Implant

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Rochester

About this trial

The purpose of this study is to compare two different bone graft materials (freeze-dried bone allograft, FDBA and collagen-enriched bovine xenograft, CEBX) that are routinely used for preserving the remaining bone after extraction of an anterior tooth, and before placing a dental implant. Patients will be randomly assigned to either group (flip of a coin) One group will receive FDBA material and the other group will receive CEBX (cow) material.

The study aims to examine the following main questions:

* Potential differences in linear radiographic horizontal (HRD) and vertical (VRD) ridge dimensional changes between groups after 16 weeks of healing * Other clinical information of the treated areas and information regarding the esthetics of the dental implant that will subsequently be placed at the edentulous site as well as patient satisfaction with the treatment, will be evaluated.

The study will include 7 study visits. Study procedures will take place during the same visits as the standard of care treatments (tooth extraction and bone graft, dental implant placement, crown installation and follow-ups). Clinical information from these standard of care visits will be used for the current research study, such as:

* Demographic information * Clinical information from intraoral photographs * Radiographic information from cone beam computed tomography and periapical radiographs.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients able to provide informed consent

patients of 18 years of age or older at time of consent and enrollment

patients in need of at least one anterior tooth extraction and seeking dental implant replacement

bone on the buccal of the central/lateral incisors or canines planned for extraction that is either intact or has a dehiscence </=5mm as determined radiographically through cone beam computed tomography (CBCT)

Disqualifiers

current smokers or tobacco-product users (self-reported)

uncontrolled diabetes (HbA1c≥7 in the last 3 months)

pregnant and/or lactating females (self-reported)

patients on immunosuppressants, steroids, bisphosphonates or other medications that have been related to Medication-Related Osteonecrosis of the Jaw (MRONJ) as described by the American Association of Oral Maxillofacial Surgeons (AAOMS) 2014 update

Trial design

Design model

Parallel

Treatments tested in this trial

  • FDBA

    Device

    Twenty five participants will receive FDBA in anterior extraction sockets as part of the alveolar ridge preservation procedure.

  • CEBX

    Device

    Twenty five participants will receive CEBX in anterior extraction sockets as part of the alveolar ridge preservation procedure.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: FDBA armExperimental treatment 1 intervention
Group B: CEBX armActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Mean change in radiographic horizontal and vertical ridge dimensions

Linear radiographic horizontal (HRD) and vertical (VRD) ridge dimensional changes will be measured and compared between groups after 16 weeks of healing.

Time frame
baseline to 16 weeks after surgery

Secondary outcomes

1

Mean change in alveolar ridge contour

Alveolar ridge contour changes as they appear on intraoral optical scans will be measured and compared between groups.

Time frame
baseline to 4 weeks after surgery
2

Mean change in alveolar ridge contour

Alveolar ridge contour changes as they appear on intraoral optical scans will be measured and compared between groups.

Time frame
baseline to 2 months after implant placement, approximately 24 weeks
3

Mean change in alveolar ridge contour

Alveolar ridge contour changes as they appear on intraoral optical scans will be measured and compared between groups.

Time frame
baseline to 12 months after implant placement, approximately 70 weeks
4

Number of implants/participants with an implant placed on a prosthetically driven position

Feasibility of prosthetically driven implant placement will be assessed with an implant planning software on the cone beam computed tomography obtained at 16 weeks after the ARP, and compared between groups

Time frame
16 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Rochester

Lead sponsor

Implant Dentistry Research & Education Foundation (IDREF)

Collaborator